Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome

Ann Hematol. 2014 Aug;93(8):1421-2. doi: 10.1007/s00277-013-1970-3. Epub 2013 Dec 5.

Authors

Carolina Cañigral¹, Federico Moscardó, Cristina Castro, Azucena Pajares, Aima Lancharro, Pilar Solves, Javier de la Rubia, Nelly Carpio, Miguel A Sanz

Affiliation

¹ Hematology Department, Hospital Universitari i Politècnic La Fe, Bulevard Sur s/n, Valencia, 46026, Spain.

PMID: 24306089
DOI: 10.1007/s00277-013-1970-3

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adult
Antibodies, Monoclonal, Humanized / therapeutic use*
Atypical Hemolytic Uremic Syndrome
Cesarean Section
Combined Modality Therapy
Female
Hemolytic-Uremic Syndrome / diagnosis
Hemolytic-Uremic Syndrome / drug therapy*
Hemolytic-Uremic Syndrome / therapy
Humans
Hysterectomy
Kidney Function Tests
Plasma Exchange
Platelet Count
Pregnancy
Pregnancy Complications, Hematologic / diagnosis
Pregnancy Complications, Hematologic / drug therapy*
Pregnancy Complications, Hematologic / therapy
Puerperal Disorders / diagnosis
Puerperal Disorders / drug therapy
Puerperal Disorders / therapy
Remission Induction
Respiration, Artificial

Substances

Adrenal Cortex Hormones
Antibodies, Monoclonal, Humanized
eculizumab